Mak­ing Genes from Scratch? Prokary­otes do too, af­ter all

by Christoph

Fig­ure 1. Size and po­si­tion of the 9 cryp­tic pro­phages in the E. coli K‑12 BW25113 genome. Source

When bac­te­ria add new  genes to their 'fex­i­ble genome' by in­te­gra­tion of a tem­per­ate phage they find them­selves in the pre­car­i­ous sit­u­a­tion of 'shared own­er­ship'. Becau­se, at any time or un­der stress­ful con­di­tions, the phage can en­ter the lytic cy­cle (spon­ta­neously or in­duced ). The phage then 're­claims own­er­ship' of its genes by ex­pres­sing them, and uses the gene prod­ucts to ex­cise from the host chro­mo­some, to repli­cate, to pack its mul­ti­plied ge­nomes into pre-formed cap­sids (phage heads ), to burst the cell, and... to leave, as a bunch of prog­eny viri­ons (= phage par­ti­cles; the orig­i­nal 'mother phage' is usu­ally left be­hind ). The 'own­er­ship is­sue' can be solved in fa­vor of the bac­te­r­ial cell by any mu­ta­tion in the prophage geno­me that pre­vents it from pro­duc­ing prog­eny (way too ma­ny pos­si­bil­i­ties ex­ist for phage‑inactivating mu­ta­tions to list them here ). Such 'in­ca­pac­i­tated' prophages have ear­ned the names 'cryp­tic prophages' or 'de­fec­tive pro­pha­ges', and there are 9 cryp­tic prophages known to re­side in the con­tem­po­rary ver­sion of the E. coli  K‑12 genome (Fig­ure 1). The­ory pre­dicts that se­lec­tion pres­sure for chro­mo­some com­paction would lead to suc­ces­sive dele­tions of those parts of cryp­tic prophages that do not carry genes whose prod­ucts con­tribute to the over­all fit­ness of the cells (a process ap­pro­pri­ately termed 'prophage de­cay' ). In­deed, the cryp­tic prophages of E. coli K‑12 to­tal only 166 kbp, con­sid­er­ably less than one would ex­pect for 9 phages of the size of phages from the λ (48.5 kbp ) or P2/P4 (33.6 kbp, 11.6 kbp ) fam­i­lies, their likely an­ces­tors.

Fig­ure 2. Ef­fi­ciency of colony for­ma­tion for the Δ9 and the wild-type strain with sub­lethal con­cen­tra­tions of nalidixic acid (2 μg/ml ) and az­lo­cil­lin (5 μg/ml ) as well as with 6% NaCl. Pow­ers of 10 in­di­cate the di­lu­tion fac­tor. Scale bar re­pre­sents 10 mm. Source

The­ory pre­dicts, in ad­di­tion, that genes ex­empt from 'pro­phage de­cay' are likely to con­tribute to the over­all fit­ness of the cells, and this has been stud­ied ex­pe­ri­men­tal­ly by a re­verse en­gi­neer­ing ap­proach. Tom Wood and his co­workers suc­ceeded in delet­ing the 9 cryp­tic pro­pha­ges with sin­gle-base pre­ci­sion, that is, in re‑creating ex­actly the chro­mo­so­mal con­text of the 'pre-prophage genome' of their strain E. coli  K‑12 BW25113. To­gether with the Δ9 strain lack­ing all cryp­tic prophages they con­structed single‑deletion strains to as­say the ef­fects of in­di­vid­ual cryp­tic prophages. The growth rates and growth yields de­ter­mined for Δ9 and BW25113 at 37°C in rich medium (LB ) and at 30°C in amino acid‑supplemented min­i­mal medium in­di­cated that BW25113 (with the 9 prophages ) faired no­tice­ably bet­ter than Δ9 (lack­ing the 9 prophages ). The single‑deletion strains gave in­ter­me­diate val­ues but the ΔCP4-57 strain came close to the de­fi­ciency of Δ9. Al­ready these re­sults made it clear that the en­sem­ble of E. coli  cryp­tic prophages con­tributes to the over­all fit­ness of the cells un­der 'nor­mal' growth con­di­tions. Un­der a num­ber of stress con­di­tions the dif­fer­ences be­came more pro­nounced. When chal­lenged with sub-lethal doses of nalidixic acid (a gy­rase in­hibitor ), sub­lethal doses of the β‑lactam an­tibi­otic azlocillin (af­fect­ing the 'sup­port stock­ings' of the cell, the pep­ti­do­gly­can ), or 6% NaCl (os­motic stress ), the pro­fi­ciency for colony fo­ma­tion was re­duced by or­ders of mag­ni­tude in the prophage-de­pleted strain Δ9 as com­pared to its 'wild-type' par­ent BW25113 (Fig­ure 2). A tran­scrip­tome analy­sis per­formed in par­al­lel led the re­searchers to de­tect that, with nalidixic acid, 17 prophage genes were in­duced >2.5‑fold in BW25113, and 43 prophage genes >2.5‑fold with azlocillin. While genes of the rac and Qin prophages were mainly re­spon­si­ble for the pro­tec­tion from azlocillin in BW25113, the yfdK, yfdO and yfdS gene prod­ucts of CP-53 were found to be re­spon­si­ble for the pro­tec­tion of BM25113 from ox­ida­tive stress (treat­ment of cells with 30 mM H2O2 for 15 min ). Taken to­gether – and omit­ting here many more of their de­tailed re­sults – this study by Tom Wood's lab shows that the 'rem­nants' of the for­mer pro­phages in the E. coli  K‑12 genome con­tribute sig­nif­i­cantly to the cells' over­all fit­ness.

Fig­ure 3. Pro­tein in­ter­ac­tion as­say in vitro. Bio­tinylated oriC DNA (bio-oriC ) binds strongly to strep­ta­vidin beads and thus 'pulls-down' pro­teins that bind to oriC from the as­say mix. Pro­teins DnaA, DnaB/C, and YfdR bind only weakly to the beads (lane 1 ). DnaA binds strongly to bio-oriC (lane 3 ); YfdR in­ter­acts with DnaA and is pulled-down but does n­ot quench DnaA-bind­ing to bio-oriC (lanes 7+8 ). DnaB/C does not bind to bio-oriC (lane 2 ); DnaB/C is teth­ered to bio-oriC by by in­ter­ac­tion with DnaA (lane 4 ). YfdR quenches the DnaB/C in­ter­ac­tion with DnaA (lanes 5+6 ). Source

One other pro­tein en­coded by the CPS-53 prophage ca­me into fo­cus very re­cently. In a screen for mul­ti­copy-sup­­pres­sors (a mu­ta­tion in one gene to be sup­pressed by over­ex­pres­sion of a sec­ond gene present on a high-copy­num­ber plas­mid ), Ya­sunori Noguchi and Tsu­tomu Katayama found that the yfdQRST genes of CPS-53 sup­press the cold-sen­si­tive growth phe­no­type of the hda– 185 ΔsfiA (sulA ) dou­ble mu­tant E. coli  strain (I know it's con­fus­ing, but briefly: Hda is a neg­a­tive reg­u­la­tor of the ini­tia­tor DnaA. The hda-185 mu­ta­tion causes se­vere overini­ti­a­tion at oriC. The ΔsfiA mu­ta­tion af­fects cell sep­tation and, in com­bi­na­tion with hda-185, pre­vents colony for­ma­tion at the non-per­mis­sive tem­per­a­ture ). By test­ing the ef­fects of the yfdQRST genes in­di­vid­u­ally the au­thors dis­cov­ered that the YfdR pro­tein (178 residues ) neg­a­tively af­fects the ini­ti­a­tion of chro­mo­some rep­li­ca­tion by in­ter­fer­ing with DnaA func­tions. One of the func­tions of oriC-bound DnaA dur­ing ini­ti­a­tion is the 'load­ing' of the he­li­case, DnaBC (6 DnaC monomers at­tached to the DnaB hexa­mer ), to the tem­porar­ily sin­gle-stranded part of the repli­ca­tion ori­gin, oriC, via di­rect protein‑pro­tein in­ter­ac­tion. They showed that in vitro  YfdR out-com­petes DnaBC for bind­ing to DnaA and thus pre­vents he­li­case load­ing (Fig­ure 3). How, then, could YfdR as an in­hibitor of repli­ca­tion ini­ti­a­tion pos­si­bly pro­vide a use­ful func­tion to wild-type cells? In­hi­bi­tion of cell di­vi­sion and of new rounds of chro­mo­some repli­ca­tion are among the first reac­tions of cells to stress (think SOS re­sponse ). There­fore, an ac­ces­sory pro­tein fac­tor that is ex­pres­sed un­der stress – as most of the cryptic‑prophage genes are, see above – and pro­motes the shut-down of chro­mo­some repli­ca­tion can come in handy. The E. coli  YfdR pro­tein and its Sal­mo­nella or­tholog YfbR are 98% iden­ti­cal (a high value even among these closely re­lated species, their DnaA pro­teins are 96% iden­ti­cal ), which points to a strong se­lec­tion for se­quence con­ser­va­tion. But also YfdR and the Shigella phage SfIV gp32 pro­tein are 98% iden­ti­cal. This sug­gests that no fur­ther mu­ta­tio­nal adap­ta­tion oc­curred in yfdR when E. coli  'adopted' it as a new gene af­ter the CPS‑53 pro­phage be­came a cryp­tic prophage (does the word 'adop­ta­tion' ex­ist? ). It also sug­gests that YfdR had, as a pro­pri­etary phage pro­tein long ago (and still has in phage SfIV ), al­ready the same func­tion: to shut-down, af­ter in­fec­tion and ex­pres­sion of the phage genes, host chro­mo­some rep­li­ca­tion by 'se­ques­ter­ing' DnaA, which is dis­pens­able for phage repli­ca­tion. This would al­low the pha­ge to 're­cruit' the com­plete set of host repli­ca­tion pro­teins (he­li­case, pri­mase, DNA poly­merase III ) for its own repli­ca­tion. Call this the perks and per­ils of 'shared own­er­ship' (if you're all for lit­er­ary ex­pres­sion­ism ) but it should be clear by now that my dif­fer­en­ti­a­tion of new genes from novel genes here isn't just nit­pick­ing.

Af­ter ar­gu­ing at length why prokary­otes rely mostly on HGT for the ac­qui­si­tion of new genes, now I make a fi­nal at­tempt to come to a con­clu­sive an­swer as to whether they make novel genes from scratch, or not at all. They do, but only few cases are known so far.

Daubin and Ochman found a small OR­Fan gene, sra (rpsV ), in the E. coli  genome that is lo­cated in be­tween the cryp­tic prophages Qin and rac but out­side the known 'ar­ray' of their genes (Fig­ure 1). The sra gene prod­uct, SRA (S22 ), had been iden­ti­fied ear­lier as a pro­tein that as­so­ciates with the small ri­bo­so­mal sub­unit pref­er­en­tially af­ter cells en­ter the sta­tion­ary phase. Whether SRA plays a role in ri­bo­some-dimer for­ma­tion (trans­la­tion­ally in­ac­tive 100S ri­bo­somes that can be rapidly re-ac­ti­vated ) dur­ing early sta­tion­ary phase is not known. It seems to be a 'lin­eage spe­cific' OR­Fan as ho­mologs of the sra gene are not found by BLAST searches in the known phage genomes, and 'out­side' the En­ter­obac­ter­aceae only in the genomes of three bac­te­ria: the Be­tapro­teobac­terium Achro­mobacter sp. ATCC13047, one Vib­rio para­haemolyti­cus iso­late (Vib­ri­onales ), and in Pe­do­bac­ter hi­malayen­sis (Bac­teroidetes ). It would need de­cent de­tec­tive work to find out whether these three ap­par­ent HGT events oc­curred in the wild or in the se­quenc­ing labs! The sra gene, al­though not novel in the strict sense to­day (the di­ver­gence of Sal­mo­nella and E. coli oc­curred >100 mil­lion years ago ), is a good can­di­date for a gene made from scratch. Strong sup­port for this hy­poth­e­sis could come from de­tect­ing the E. coli  gene or­der adhP·maeA·sra·bdm·osmC  in an­other bac­te­r­ial genome with the sra open read­ing frame miss­ing (this ap­proach was suc­cess­ful in the case of the yeast BSC4 gene, see the pre­vi­ous post ). How­ever, the com­plete gene con­text is not con­served out­side Es­cherichia, Shigella, and Sal­mo­nella, which makes this straight­for­ward search ap­proach un­fea­si­ble. The 'core' con­text maeA·sra·bdm is still present in most but not all Cit­robac­ter and En­terobacter species, and maeA is sep­a­rated from sra and bdm in most Kleb­siella species (my own quick & dirty BLAST search ef­fort ). There­fore, sra re­mains a can­di­date novel gene for now.

Fig­ure 4. Over­lap­ping yaaW and htgA genes in E. coli. Num­bers in­di­cate nu­cleotide residue for yaaW gene. The ini­ti­a­tion codon of hgtA has been pre­dicted to be in nu­cleotide 632 [14], and more re­cently in 527 [23]. A gray box in­di­cates the re­gion where we have de­tected a low­er­ing in the rate of evo­lu­tion of yaaW se­quences with an htgA over­lap­ping gene. Source

If Prokary­otes are re­stricted from mak­ing novel genes in in­ter­genic re­gions they could re­sort to evolve them with­in ex­ist­ing genes, a process that has been dubbed 'over­printing' and was pro­posed in 1977 by Grassé and later sub­stan­ti­ated by Ohno. 'Over­print­ing', that is, over­lap­ping genes are fairly com­mon in virus genomes, which are con­strained in genome sizes due to the vol­ume lim­its set by their cap­sids (8 of the 11 genes over­lap in the first-ever se­quenced genome, the 5,386 nu­cleotides-long cir­cular sin­gle-stranded DNA of phage ΦX174 ).

More re­cently, De­laye et al. found one case for fully over­lapping genes in E. coli , the yaaW  and htgA  genes, en­co­ded by com­ple­men­tary DNA strands (Fig­ure 4). The htgA  gene en­codes a pos­i­tive reg­u­la­tor of the σ32 heat-shock pro­moter, the func­tion of the yaaW  gene prod­uct is not known. In this case, the yaaW  gene ap­pears to be the 'older' gene as it is evo­lu­tio­na­ry con­served, with ho­mologs not only within the Gammapro­teobac­te­ria but also in An­abaena (Cyanobac­te­ria), Fu­sobac­terium (Fu­sobac­te­ria), and sev­eral Ep­silon­pro­teobac­te­ria. The hgtA  gene, on the other hand, ap­pears to be a novel gene, re­stricted to sev­eral but not all Es­cherichia coli  and Shigella strains; it is not present in Sal­mo­nella.

But there's more in the mi­cro­bial world than just E. coli, and an in­tri­cate case of 'over­print­ing' was re­vealed by stud­ies of a small reg­u­la­tory RNA of Bacil­lus sub­tilis. The 205 nt long SR1 sRNA had been shown ear­lier to reg­u­late, by base-pair­ing, the 'trans­lata­bil­ity' of the ahrC mRNA (AhrC is a tran­scrip­tional ac­ti­va­tor of the ro­cABC and rocDEF argi­nine cata­bolic oper­ons ). SR1 does not act like the con­ven­tional an­ti­sense RNAs by block­ing (through base-pair­ing ) the 5'‑end of mR­NAs to pre­vent trans­la­tion but binds ~100 nt down­stream of the 5'-end of ahrC  mRNA and in­hibits trans­lation by in­duc­ing struc­tural changes down­stream of the ahrC  ri­bo­some-bind­ing site (RBS). Now it was found that the SR1 sRNA is also trans­lated to yield the 39-residue l SR1P pro­tein that binds to the gly­colytic en­zyme GapA and sta­bi­lizes, by an as yet un­known mol­e­c­u­lar mech­a­nism, the gapA  mRNA. This 'dual function'-gene SR1, with the trans­lated pro­tein be­ing the novel part, is con­served among Bacil­lus, Geobacil­lus, Anoxy­bacil­lus, and Bre­vibacil­lus species and there­fore not re­ally 'brand new'.

To con­clude: Yes, cells make novel genes from scratch still, even af­ter >2 bil­lion years of evo­lu­tion. Nei­ther eu­kar­yo­tic nor prokary­otic cells suc­ceed in do­ing that very of­ten al­though at least eu­kar­yo­tic cells may try more of­ten than gen­er­ally as­sumed. If cells suc­ceed in mak­ing a novel gene, its es­tab­lish­ment in the genome must take a long time, eas­ily sev­eral mil­len­nia, and in any case more than 'just a few gen­er­a­tions'. The known ex­am­ples demon­strate that such novel genes – and also new genes aquired via HGT – are pos­i­tively se­lected if their gene prod­ucts con­fer an adap­tive ad­vantage, even when only in­cre­men­tal, and if they 'fit' into ex­ist­ing reg­u­la­tory net­works of the cells. These lat­ter con­straints make it pretty clear that at­tempts, as tempt­ing as they are, to learn how the first genes were made at the very be­gin­ning by study­ing the way novel genes are made to­day are of no avail. That's some­how dis­ap­point­ing, isn't it?

Fron­tispiece: pic­ture by Bud­dhini Sama­ras­inghe, from her blog jar­gonwall.

 

Other Posts